# Digestive Disease Week (DDW) 2023 Conflicts of Interest
List of conflicts of interest for **The Global Evolution of Inflammatory Bowel Disease across Four Epidemiologic Stages: A Systematic Review of Incidence and Prevalence Studies over the Past Century**.

**Joseph W. Windsor**: None declared.<br>
**Lindsay Hracs**: None declared.<br> 
**Julia Gorospe**: None declared.<br>
**Stephanie Coward**: None declared.<br>
**Michael Buie**: None declared.<br>
**Joshua Quan**: None declared.<br>
**Ante Markovinvić**: None declared.<br>
**Léa Caplan**: has received a research grant from AbbVie.<br>
**Michael Cummings**: None declared.<br>
**Richard Gearry**: has received honoraria, consultancy, or research grants from AbbVie, Janssen, Celltrion, Takeda, Ferring, and Zespri.<br>
**Paulo Kotze**: has received speaking and consultancy honorarium from Pfizer, Janssen, Takeda, AbbVie, and Novartis, and also has received scientific grants from Takeda and Pfizer; Maria T. Abreu has consulted or served on advisory boards for AbbVie, Inc, Bristol Myers Squibb, Eli Lilly Pharmaceuticals, Gilead, Janssen Ortho, LLC, Prometheus Biosciences, Microba, and UCB Biopharma, has taught, lectured, or served as a speaker for Alimentiv, Arena Pharmaceuticals, Janssen, Prime CME, Takeda Pharmaceuticals, and Intellisphere, LLC (HCP Live Institutional Perspectives in GI), and has received grants/research support from Prometheus, Takeda, and Pfizer.<br>
**Maria T. Abreu**: has consulted or served on advisory boards for AbbVie, Inc, Bristol Myers Squibb, Eli Lilly Pharmaceuticals, Gilead, Janssen Ortho, LLC, Prometheus Biosciences, Microba, and UCB Biopharma, has taught, lectured, or served as a speaker for Alimentiv, Arena Pharmaceuticals, Janssen, Prime CME, Takeda Pharmaceuticals, and Intellisphere, LLC (HCP Live Institutional Perspectives in GI), and has received grants/research support from Prometheus, Takeda, and Pfizer.<br>
**David T. Rubin**: has received grant support from Takeda, and has served as a consultant for AbbVie, Altrubio, Arena Pharmaceuticals, Bristol-Myers Squibb, Genentech/ Roche, Gilead Sciences, Iterative Scopes, Janssen Pharmaceuticals, Lilly, Pfizer, Prometheus Biosciences, Takeda, and Techlab, Inc.<br>
**Iris Dotan**: Receipt of grants/research supports:  Altman Research, Pfizer, BMS; Receipt of honoraria or consultation fees: Abbott, AbbVie, Athos, Arena, Cambridge Healthcare, Celltrion, Celgene/BMS, Ferring, Food Industries Organization, Gilead, Galapagos, Iterative Scopes, Integra Holdings, Janssen, Pfizer, Roche/Genentech, Sangamo, Sublimity, Sandoz, Takeda, Wildbio, Prometheus; Participation in a company sponsored speaker’s bureau:  Abbvie, Celltrion, Celgene/BMS, Ferring, Food Industries Organization, Gilead, Galapagos, Janssen, Pfizer, Roche/Genentech, Sandoz, Takeda; Stock shareholder: Harp Diagnostics.<br>
**Charles Bernstein**: Grant / Research support from: Unrestricted educational grants from AbbVie Canada, Janssen Canada, Pfizer Canada, Bristol Myers Squibb Canada, and Takeda Canada. Has received research grants from AbbVie Canada, Amgen Canada, Pfizer Canada, and Sandoz Canada and contract grants from Janssen, AbbVie and Pfizer, Consultant of: AbbVie Canada, Amgen Canada, Bristol Myers Squibb Canada, JAMP Pharmaceuticals, Janssen Canada, Pfizer Canada, Sandoz Canada, and Takeda. Speakers bureau of: AbbVie Canada, Janssen Canada, Pfizer Canada and Takeda Canada.<br>
**Remo Panaccione**: Consultant of: Abbott, AbbVie, Alimentiv (formerly Robarts), Amgen, Arena Pharmaceuticals, AstraZeneca, Biogen, Boehringer Ingelheim, Bristol-Myers Squibb, Celgene, Celltrion, Cosmos Pharmaceuticals, Eisai, Elan, Eli Lilly, Ferring, Galapagos, Fresenius Kabi, Genentech, Gilead Sciences, Glaxo- Smith Kline, JAMP Bio, Janssen, Merck, Mylan, Novartis, Oppilan Pharma, Organon, Pandion Pharma, Pendopharm, Pfizer, Progenity, Protagonist Therapeutics, Roche, Sandoz, Satisfai Health, Shire, Sublimity Therapeutics, Takeda Pharmaceuticals, Theravance Biopharma, Trellus, Viatris, UCB. Advisory Boards for: AbbVie, Alimentiv (formerly Robarts), Amgen, Arena Pharmaceuticals, AstraZeneca, Biogen, Boehringer Ingelheim, Bristol-Myers Squibb, Celgene, Eli Lilly, Ferring, Fresenius Kabi, Genentech, Gilead Sciences, Glaxo-Smith Kline, JAMP Bio, Janssen, Merck, Mylan, Novartis, Oppilan Pharma, Organon, Pandion Pharma, Pfizer, Progenity, Protagonist Therapeutics, Roche, Sandoz Shire, Sublimity Therapeutics, Takeda Pharmaceuticals, Speakers bureau of: AbbVie, Amgen, Arena Pharmaceuticals, Bristol-Myers Squibb, Celgene, Eli Lilly, Ferring, Fresenius Kabi, Gilead Sciences, Janssen, Merck, Organon, Pfizer, Roche, Sandoz, Shire, Takeda Pharmaceuticals.<br>
**Siew C. Ng**: has received honoraria for speaking or consultancy for Janssen, AbbVie, Takeda, Ferring, Tilotts, Menarini, and Pfizer, and has received research support from Olympus, Ferring, Janssen, and AbbVie.<br>
**Gilaad G. Kaplan**: Grant / Research support from: Ferring, Janssen, AbbVie, GlaxoSmith Kline, Merck, and Shire, Consultant of: Gilead, Speakers bureau of: AbbVie, Janssen, Pfizer, Amgen, and Takeda.
